Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11771 | 891 | 44.1 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1187 | 8873 | RESTENOSIS//INTRAVASCULAR BRACHYTHERAPY//TRANILAST |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEMAGGLUTINATING VIRUS OF JAPAN | Author keyword | 4 | 36% | 1% | 8 |
2 | GAX | Author keyword | 3 | 32% | 1% | 8 |
3 | HVJ LIPOSOME | Author keyword | 3 | 22% | 1% | 10 |
4 | CARDIOVASC MED BIOL | Address | 2 | 67% | 0% | 2 |
5 | VIRAL LIPOSOME | Author keyword | 2 | 67% | 0% | 2 |
6 | VASC GENE THER Y UNIT | Address | 2 | 50% | 0% | 3 |
7 | CARDIOVASCULAR GENE THERAPY | Author keyword | 2 | 43% | 0% | 3 |
8 | VASCULAR GENE THERAPY | Author keyword | 2 | 33% | 0% | 4 |
9 | ARTERIAL GENE TRANSFER | Author keyword | 1 | 100% | 0% | 2 |
10 | CARDIOVASC GENE THER Y | Address | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEMAGGLUTINATING VIRUS OF JAPAN | 4 | 36% | 1% | 8 | Search HEMAGGLUTINATING+VIRUS+OF+JAPAN | Search HEMAGGLUTINATING+VIRUS+OF+JAPAN |
2 | GAX | 3 | 32% | 1% | 8 | Search GAX | Search GAX |
3 | HVJ LIPOSOME | 3 | 22% | 1% | 10 | Search HVJ+LIPOSOME | Search HVJ+LIPOSOME |
4 | VIRAL LIPOSOME | 2 | 67% | 0% | 2 | Search VIRAL+LIPOSOME | Search VIRAL+LIPOSOME |
5 | CARDIOVASCULAR GENE THERAPY | 2 | 43% | 0% | 3 | Search CARDIOVASCULAR+GENE+THERAPY | Search CARDIOVASCULAR+GENE+THERAPY |
6 | VASCULAR GENE THERAPY | 2 | 33% | 0% | 4 | Search VASCULAR+GENE+THERAPY | Search VASCULAR+GENE+THERAPY |
7 | ARTERIAL GENE TRANSFER | 1 | 100% | 0% | 2 | Search ARTERIAL+GENE+TRANSFER | Search ARTERIAL+GENE+TRANSFER |
8 | GENE ELUTING STENTS | 1 | 100% | 0% | 2 | Search GENE+ELUTING+STENTS | Search GENE+ELUTING+STENTS |
9 | IN VIVO ARTERIAL GENE TRANSFER | 1 | 100% | 0% | 2 | Search IN+VIVO+ARTERIAL+GENE+TRANSFER | Search IN+VIVO+ARTERIAL+GENE+TRANSFER |
10 | IN VIVO GENE TRANSDUCTION | 1 | 100% | 0% | 2 | Search IN+VIVO+GENE+TRANSDUCTION | Search IN+VIVO+GENE+TRANSDUCTION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NORMAL RABBIT ARTERIES | 19 | 64% | 2% | 18 |
2 | EXPRESSION INVIVO | 17 | 39% | 4% | 35 |
3 | C MYB OLIGONUCLEOTIDES | 13 | 48% | 2% | 20 |
4 | RAT CAROTID ARTERY | 12 | 13% | 10% | 89 |
5 | ANTISENSE CDC2 | 12 | 86% | 1% | 6 |
6 | INTRAVASCULAR DRUG DELIVERY | 9 | 83% | 1% | 5 |
7 | ENGINEERED ENDOTHELIAL CELLS | 9 | 67% | 1% | 8 |
8 | MODIFIED ENDOTHELIAL CELLS | 9 | 67% | 1% | 8 |
9 | ATHEROSCLEROTIC ARTERIES | 8 | 45% | 2% | 14 |
10 | REDUCES NEOINTIMA FORMATION | 7 | 42% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cardiovascular gene therapy | 2000 | 208 | 139 | 26% |
Nanoparticle Drug-and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis | 2014 | 2 | 182 | 29% |
Gene therapy for restenosis | 2000 | 34 | 37 | 86% |
Nitric oxide synthase gene therapy for cardiovascular disease | 2002 | 27 | 75 | 47% |
Nitric oxide synthase gene therapy: progress and prospects | 2009 | 19 | 99 | 25% |
Current status of catheter- and stent-based gene therapy | 2004 | 34 | 60 | 45% |
Cell cycle progression - New therapeutic target for vascular proliferative disease | 1998 | 211 | 105 | 21% |
Nanoparticulate carriers for the treatment of coronary restenosis | 2007 | 24 | 145 | 32% |
Gene therapy for restenosis: Biological solution to a biological problem | 2007 | 11 | 85 | 47% |
Restenosis: a challenge for pharmacology | 2000 | 50 | 44 | 34% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIOVASC MED BIOL | 2 | 67% | 0.2% | 2 |
2 | VASC GENE THER Y UNIT | 2 | 50% | 0.3% | 3 |
3 | CARDIOVASC GENE THER Y | 1 | 50% | 0.2% | 2 |
4 | PRECLIN BIOL IMMUNOL | 1 | 33% | 0.3% | 3 |
5 | ANESTHESIA BIOMED ENGN | 1 | 50% | 0.1% | 1 |
6 | BIOL SCI MOL BIOL | 1 | 50% | 0.1% | 1 |
7 | BIOPHARMCEUT | 1 | 50% | 0.1% | 1 |
8 | BIOTECHNOL GENET EXPT | 1 | 50% | 0.1% | 1 |
9 | CLIN GEN VASC SURG TRANSPLANTOL | 1 | 50% | 0.1% | 1 |
10 | CNR COMPOSITE BIOMED MAT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000232014 | LOCAL DRUG DELIVERY//HIRULOG LIKE PEPTIDE//ANGIOPEPTIN |
2 | 0.0000204275 | TRANSCRIPTION FACTOR DECOY//DECOY//DECOY OLIGODEOXYNUCLEOTIDE |
3 | 0.0000158094 | COLD INDUCED HYPERTENSION//ANTISENSE ELEMENTS//AT1 RECEPTOR ANTISENSE |
4 | 0.0000155283 | VEIN GRAFT//VEIN GRAFTS//INTIMAL HYPERPLASIA |
5 | 0.0000125941 | MOL MED GENE THER Y UNIT//GUTLESS//HELPER DEPENDENT ADENOVIRUS |
6 | 0.0000121519 | ARTERIOGENESIS//THERAPEUTIC ANGIOGENESIS//GRP EXPT CLIN ARTERIOGENESIS |
7 | 0.0000115687 | GLC OXLDL//MOL VASC CELL BIOL//PATHOL AZ MIDDELHEIM |
8 | 0.0000113148 | RAT AORTIC SMOOTH MUSCLE CELL//CINNAMOMUM CASSIA BARK//CLITOCYBIN A |
9 | 0.0000096285 | VIROSOMES//FUSOGENIC LIPOSOME//VIROSOME |
10 | 0.0000086002 | CTHRC1//COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1//CAROTID ARTERY RESTENOSIS |